TP53 and cancer: Recent next generation sequencing studies have identified recurrent somatic mutations in a number of potential cancer genes, such as the chromatin remodeling genes ARID1A, MLL3 and MLL, the cell adhesion gene FAT4, the lipid kinase PIK3CA and the P53 tumor-suppressor gene.